These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2505880)

  • 1. Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approaches.
    Arnold R; Bartram CR; Heinze B; Carbonell F; Wiesneth M; Hertenstein B; Schmeiser T; Heit W; Kubanek B; Heimpel H
    Bone Marrow Transplant; 1989 Jul; 4(4):389-92. PubMed ID: 2505880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow transplantation in chronic myeloid leukemia].
    Milone JH; Bordone J; Etchegoyen O; Napal J; Prates MV; Morales VH
    Medicina (B Aires); 1999; 59(1):1-10. PubMed ID: 10349111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular cytogenetic monitoring of chimerism and minimal residual disease in patient with chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation].
    Vinogradova OA; Savchenko VG; Domracheva EV; Liubimova LS; Ol'shanskaia IuV; Diachenko LV; Parovichnikova EN; Mendeleeva LP; Zakharova AV
    Ter Arkh; 2002; 74(7):38-44. PubMed ID: 12181833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease in chronic myeloid leukaemia.
    Cross NC
    Hematol Cell Ther; 1998 Oct; 40(5):224-8. PubMed ID: 9844816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase.
    Frassoni F; Martinelli G; Saglio G; Sessarego M; Podestà M; Piaggio G; Farabegoli P; Zaccaria A; Testoni N; Remiddi C
    Bone Marrow Transplant; 1995 Oct; 16(4):595-601. PubMed ID: 8528178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E; Krahl R; Thalmeier K; Helbig W
    Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical factors that affect the detection of BCR-ABL transcripts after allogenic bone marrow transplantation for chronic myeloid leukemia].
    Román J; García MJ; Martín C; Sánchez J; Serrano J; Falcón M; Castillejo JA; Navarro JA; Flores R; Torres A
    Med Clin (Barc); 1998 Oct; 111(11):405-9. PubMed ID: 9834912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patients.
    Zaccaria A; Rosti G; Sessarego M; Frassoni F; Marmont A; Galimberti M; Baronciani D; Filippetti A; Di Bartolomeo P; Di Girolamo G
    Bone Marrow Transplant; 1988 Sep; 3(5):413-23. PubMed ID: 3056550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia.
    Xu WM; Piao XH; Addy L; Jamal M; Minden MD; Messner HA
    Bone Marrow Transplant; 1994 Aug; 14(2):299-306. PubMed ID: 7994246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimal residual disease in chronic myeloid leukemia in patients with long survival after allogeneic bone marrow transplantation].
    García A; Román J; Brunet S; Andrés P; Baiget M; Torres A
    Med Clin (Barc); 1995 Mar; 104(11):401-6. PubMed ID: 7715257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
    Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
    Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.